Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing recombinant human luteinizing hormone (r-hLH) with urinary human chorionic gonadotrophin (u-hCG) to trigger ovulation in infertile wom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Recombinant human luteinizing hormone (lutropin alfa)
• Urinary human chorionic gonadotrophin (urinary human chorionic gonadotrophin)

Snippet

Sponsor: Merck KGaA, Darmstadt, Germany | Conditions: Infertility | Phase 2 | Status: COMPLETED